During the past decade, JEM Research Institute conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 26 clinical trials were completed, i.e. on average, 51% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 21 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JEM Research Institute" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Biogen" with 5 trials sponsored, "Neurotrope Bioscience, Inc." with 3 trials sponsored and "TauRx Therapeutics Ltd" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JEM Research Institute" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator and "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "JEM Research Institute" are "Alzheimer Disease" (19 trials), "Alzheimer's Disease" (12 trials), "Mild Cognitive Impairment" (4 trials), "Parkinson Disease" (3 trials) and "Constipation" (2 trials). Many other conditions were trialed in "JEM Research Institute" in a lesser frequency.

Most popular intervention types in "JEM Research Institute" are "Drug" (52 trials), "Other" (7 trials), "Biological" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "placebo" (5 trials), "Aducanumab" (4 trials), "Donanemab" (4 trials) and "ATH-1017" (2 trials). Other intervention names were less common.

The vast majority of trials in "JEM Research Institute" are 58 trials for "All" genders.

Currently, there are NaN active trials in "JEM Research Institute". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in JEM Research Institute, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in JEM Research Institute, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".